DR. ARMANDO E. GIULIANO, MD, FACS, FRCSED
Radiology at Beverly Blvd, Los Angeles, CA
License number
California A43778
Category
Radiology
Type
Surgical Oncology
Address
Address
8700 Beverly Blvd, Los Angeles, CA 90048
Phone
(310) 423-9970
(310) 423-9577 (Fax)
(310) 423-9577 (Fax)
Personal information
See more information about ARMANDO E. GIULIANO at radaris.comName
Address
Phone
267 N Tigertail Rd, Los Angeles, CA 90049
1328 22Nd St, Santa Monica, CA 90404
267 Tigertail Rd, Los Angeles, CA 90049
Professional information
Dr. Armando E Giuliano, West Hollywood CA - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
310 N San Vicente Blvd, West Hollywood 90048
(310) 423-9970 (Phone)
Cedars Sinai Sal/Joyce Brandman
310 N San Vicente Blvd SUITE 300, Los Angeles 90048
(310) 423-9331 (Phone)
(310) 423-9970 (Phone)
Cedars Sinai Sal/Joyce Brandman
310 N San Vicente Blvd SUITE 300, Los Angeles 90048
(310) 423-9331 (Phone)
Procedures:
Appendectomy, Open, Biopsy of Breast, Breast Reconstruction, Breast Surgical Procedures, Excision of Breast Tumor, Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer, Lymph Node Biopsy or Excision, Mastectomy, Parathyroid Surgery, Parathyroidectomy, Port Placements or Replacements, Thyroid Surgery, Thyroidectomy or Thyroid Lobectomy
Conditions:
Appendicitis, Breast Cancer, Breast Diseases, Breast Lump/Mass, Carcinoma in Situ, Diaphragmatic/Hiatal Hernia, Empyema, Hidradenitis, Hyperparathyroidism, Lipomas, Lung Cancer, Parathyroid (Gland) Cancer, Parathyroid (Gland) Disease, Parathyroid (Gland) Tumor: Other than Malignant, Peripheral Vascular Disease (PAD, PVD), Rib Fracture, Secondary Malignancies, Thyroid Cancer, Ulcerative Colitis
Certifications:
General Surgery, 1999
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
310 N San Vicente Blvd, West Hollywood 90048
Cedars Sinai Sal/Joyce Brandman
310 N San Vicente Blvd SUITE 300, Los Angeles 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Cedars Sinai Sal/Joyce Brandman
310 N San Vicente Blvd SUITE 300, Los Angeles 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Education:
Medical School
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1973
Uc San Francisco Med Center
Graduated: 1974
Graduated: 1980
UCLA Med Center
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1973
Uc San Francisco Med Center
Graduated: 1974
Graduated: 1980
UCLA Med Center
Armando E Giuliano, West Hollywood CA
Specialties:
Surgeon
Address:
310 N San Vicente Blvd, West Hollywood, CA 90048
1328 22Nd St, Santa Monica, CA 90404
8700 Beverly Blvd, West Hollywood, CA 90048
1328 22Nd St, Santa Monica, CA 90404
8700 Beverly Blvd, West Hollywood, CA 90048
Education:
University of Chicago, Pritzker School of Medicine - Doctor of Medicine
Ronald Reagan UCLA Medical Center - Fellowship - Surgical Oncology
University of California, San Francisco - Medical Center - Residency - Surgery
Ronald Reagan UCLA Medical Center - Fellowship - Surgical Oncology
University of California, San Francisco - Medical Center - Residency - Surgery
Board certifications:
American Board of Surgery Certification in Surgery
Armando Elario Giuliano, West Hollywood CA
Specialties:
Surgery, Surgical Oncology, Hematology, Hematology & Oncology
Work:
Cedars-Sinai Medical Center
310 N San Vicente Blvd, Los Angeles, CA 90048
310 N San Vicente Blvd, Los Angeles, CA 90048
Education:
University of Chicago (1973)
Method For Predicting Response Of Cancer Patient To Anticancer Drug Treatment
US Patent:
2010006, Mar 18, 2010
Filed:
Sep 2, 2009
Appl. No.:
12/584357
Inventors:
Armando E. Giuliano - Los Angeles CA, US
Dave S. Hoon - Los Angeles CA, US
Hideki Ishihara - Miki-shi, JP
Dave S. Hoon - Los Angeles CA, US
Hideki Ishihara - Miki-shi, JP
International Classification:
C12Q 1/48
US Classification:
435 15
Abstract:
A method predicts a response of a cancer patient to anticancer drug based on a cell cycle profile score obtained by analyzing a malignant tumor of the cancer patient, wherein the method can predict a disease outcome including a complete response, a partial response, stable disease, no response, and time to progression of disease as patient's response to anticancer drug therapy.